激光衍生成像在系统性硬化相关指端血管病变临床试验中评估指端灌注的性能:系统文献综述
该系统综述评估激光多普勒血流仪、激光多普勒成像和激光散斑对比成像作为系统性硬化相关指端血管病变临床试验结局指标的性能。共纳入29项研究(689例患者),多数研究报告干预后指端灌注改善。全视野指端灌注(伴或不伴激发试验)是有前景的临床试验结局指标。
要点
- 激光衍生成像可无创量化指端灌注,可能作为SSc-RP和/或SSc-DU临床试验的结局指标。
- 29项研究中16项(55%)报告干预后指端灌注改善,常与患者和临床医生 derived 结局一致。
- 全视野指端灌注(伴或不伴激发试验)是SSc相关指端血管病变临床试验的有前景结局指标。
核心结论
- 确立激光衍生方法作为SSc相关指端血管病变的替代指标将极大支持药物开发。
- 全视野指端灌注(伴或不伴激发试验)是SSc相关指端血管病变临床试验的有前景结局指标。
研究设计与样本
- 系统文献综述,标准化检索EMBASE和MEDLINE,纳入成人SSc患者中采用激光衍生成像评估指端血管病变的试验。
- 从126篇文献中全文提取29项研究数据,由超过2名评价者提取研究设计、激光终点和报告结局,使用验证工具评估研究质量(PROSPERO 2019:CRD42019142409)。
主要发现
- 29项研究包括15项随机和14项非随机试验,共689例SSc患者,平均每项研究23.8例。
- 研究评估了口服、静脉和局部干预,针对SSc-RP(n=11)、仅指端灌注(n=15)和SSc-DU(n=3)。
- 研究发表于1987年至2019年(17/29自2010年起),采用LDF(11/29)、LDI(15/29)和LSCI(4/29,包括一项同时用LDF);LSCI和LDI更常用于近期试验。
- 多数研究(16/29,55%)报告干预后指端灌注改善,常与患者和临床医生 derived 结局一致。
临床怎么用
- 激光衍生成像可作为SSc相关指端血管病变临床试验中评估指端灌注的结局指标。
- 全视野指端灌注(伴或不伴激发试验)值得在SSc相关指端血管病变临床试验中进一步应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Raynaud's phenomenon (RP) and digital ulcers (DU) are important features of digital vasculopathy in systemic sclerosis (SSc). Laser Doppler flowmetry (LDF), Laser Doppler Imaging (LDI) and Laser Speckle Contrast Imaging (LSCI) can non-invasively quantify digital perfusion and may be useful outcome measures for SSc-RP and/or SSc-DU clinical trials. We undertook a systematic literature review to evaluate the performance of laser-derived imaging as outcome measures in clinical trials of SSc-related digital vasculopathy. METHODS: Standardized searches (EMBASE and MEDLINE) identified trials that incorporated laser-derived imaging of digital vasculopathy in adult subjects with SSc. Data was extracted (by >2 reviewers) on study design, laser endpoints, and reported outcomes. Study quality was assessed using validated instruments (PROSPERO 2019:CRD42019142409). RESULTS: Of 126 identified articles, full data extraction was undertaken from 29 studies. Fifteen randomized and 14 non-randomized trials (total of 689 SSc patients with mean 23.8/study) have evaluated a broad range of oral, intravenous and topical interventions for SSc-RP (n = 11), digital perfusion alone (n = 15) and SSc-DU (n = 3). The studies were published between 1987 and 2019 (17/29 since 2010) and incorporated LDF (11/29), LDI (15/29) and LSCI (4/29, including one with LDF); with LSCI and LDI more commonly incorporated in recent trials. Most studies (16/29, 55%) reported improvement in digital perfusion following intervention, often concordant with patient- and clinician-derived outcomes. CONCLUSIONS: Establishing laser-derived methods as a surrogate for SSc-related digital vasculopathy will greatly support drug development. Full-field perfusion of the digits (with/without provocation testing) is a promising clinical trial outcome measure for trials of SSc-related digital vasculopathy.
引用
- Pauling JD, Hackett N, Guida A, et al. Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review. Semin Arthritis Rheum. 2020. PMID: 32920325. doi:10.1016/j.semarthrit.2020.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。